Antibiotic Resistance of Bacterial Vascular Access Infection in Hemodialysis Patients
International Journal of Drug Delivery Technology · 29.05.2026 · 16 (34s)
DOI: 10.25258/ijddt.16.34s.37 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.05.2026. Verfasst von Mohamed Fawzy Musallam und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) are at high risk for vascular access-related infections due to immunosuppression, repeated hospitalizations, and frequent vascular interventions. Catheterrelated bloodstream infections (CRBSIs) are the most common, predominantly caused by Staphylococcus aureus, coagulase-negative staphylococci, and Gram-negative bacteria. Infection risk is influenced by vascular access type, catheter insertion site, antibiotic exposure, and healthcare facility practices. CRBSIs are often complicated by biofilm formation, reducing antibiotic susceptibility and necessitating catheter removal or adjunctive therapies such as antibiotic locks or guidewire exchange. Prevention strategies include use of arteriovenous fistulas, strict hand hygiene, contact precautions, topical decolonization, and antibiotic/antiseptic-coated catheters. Antimicrobial resistance (AMR) in HD patients is a growing concern, with multidrug-resistant organisms, including methicillinresistant S. aureus and carbapenem-resistant Klebsiella pneumoniae, contributing to increased morbidity, mortality, and healthcare costs. AMR arises via intrinsic or acquired mechanisms, including mutations and horizontal gene transfer, often facilitated by mobile genetic elements. Effective management of CRBSIs requires timely empirical antibiotics, guided by local antibiograms, combined with source control and catheter management. Screening, decolonization, and strict infection control are essential to limit colonization and prevent systemic infections.
Zitieren
APA
Musallam, M. F., Taha, M. A. S., Mahmoud, A. Y. G., & Hasanein, M. W. S. (2026). Antibiotic Resistance of Bacterial Vascular Access Infection in Hemodialysis Patients. International Journal of Drug Delivery Technology, 16(34s). https://doi.org/10.25258/ijddt.16.34s.37
Vancouver
Musallam MF, Taha MAS, Mahmoud AYG, Hasanein MWS. Antibiotic Resistance of Bacterial Vascular Access Infection in Hemodialysis Patients. International Journal of Drug Delivery Technology. 2026;16(34s). doi:10.25258/ijddt.16.34s.37
BibTeX
@article{Musallam2026,
author = {Musallam, Mohamed Fawzy and Taha, Mohamed Ahmed Shaarawi and Mahmoud, Ahmed Yousry Gamil and Hasanein, Mohamed W. Saleh},
title = {Antibiotic Resistance of Bacterial Vascular Access Infection in Hemodialysis Patients},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {34s},
doi = {10.25258/ijddt.16.34s.37}
}
EUVIMED